Pantoprazole 20mg tablets is a UK Prescription Only Medicine and a member of the proton pump inhibitor (PPI) class, used for the treatment and prevention of conditions where reducing stomach acid production is clinically beneficial.
The standard adult dose is one 20mg tablet once daily, taken in the morning, about an hour before food.
Notable for its particularly clean drug interaction profile compared to other PPIs, making it the preferred choice for patients on clopidogrel, methotrexate, or multiple medicines.
Available from Courier Pharmacy after a quick online consultation reviewed by a UK-qualified prescriber, with optional free pharmacist support before or after you order.
Pantoprazole 20mg tablets are a UK Prescription Only Medicine (POM). Clinicians use them to treat and maintain acid-related conditions where lowering stomach acid helps. For example, they can support GORD (acid reflux) control and help prevent symptoms from coming back.
Each tablet contains 20mg of pantoprazole (usually as pantoprazole sodium sesquihydrate). The tablet has a gastro-resistant (enteric) coating. So, it passes through the stomach without breaking down. Then it releases pantoprazole in the small intestine. After that, your body absorbs it and carries it to the acid-producing cells in the stomach lining.
How pantoprazole works
Pantoprazole is a proton pump inhibitor (PPI). It blocks the proton pump, which drives the final step in stomach acid production. As a result, it reduces acid strongly and for longer.
This steady acid control matters. It can help heal irritation in the oesophagus. It also helps keep reflux symptoms under control.
Why clinicians often choose pantoprazole (drug interactions)
Pantoprazole stands out for its cleaner interaction profile. It has low inhibition of CYP2C19, a liver enzyme that helps process many medicines. Therefore, pantoprazole tends to interfere less with other treatments than some other PPIs.
This can matter if you take medicines such as:
clopidogrel
warfarin
phenytoin
diazepam
citalopram
methotrexate
In fact, NICE and the BNF highlight pantoprazole as a preferred PPI option for people who take clopidogrel.
When 20mg is the right dose
The 20mg dose often suits mild to moderate reflux. It also works well as a maintenance dose once symptoms settle. In addition, the 20mg tablet is usually smaller than the 40mg tablet. So, many people find it easier to swallow.
Clinicians often use 40mg for more severe disease. For example, they may use it for reflux oesophagitis, ulcer treatment, H. pylori regimens, or Zollinger–Ellison syndrome. After healing, they may step down to 20mg for long-term control.
Generic pantoprazole 20mg from Courier Pharmacy
We supply licensed UK pantoprazole 20mg tablets, including generic versions. UK-licensed manufacturers make these products to the same regulatory standards as the originator brands (such as Protium / Pantoloc). They also meet bioequivalence requirements. So, you get the same active medicine at a lower cost.
Prescriber review and clinical checks
We supply Pantoprazole 20mg tablets from a UK-registered pharmacy after an online consultation. A UK-qualified prescriber reviews your answers first.
The consultation covers:
your symptoms and how long they’ve lasted
your medical history and previous PPI use
your current medicines (this often guides the best PPI choice)
your treatment goals
If 20mg does not fit your needs, the prescriber may suggest another strength, a different PPI, or a referral. That way, you get safe treatment that matches the bigger picture.
Key features and specifications
Active ingredient: Pantoprazole 20mg per tablet (usually as pantoprazole sodium sesquihydrate)
Form: Gastro-resistant tablets (swallow whole with water)
Pack size: 28 tablets (standard 28-day supply)
Indications: Mild to moderate GORD, mild reflux oesophagitis, long-term maintenance of reflux disease, prevention of NSAID-associated ulcers
Standard adult dose: 20mg once daily, usually in the morning about 1 hour before food
Legal category: Prescription Only Medicine (POM)
Supplied by: Courier Pharmacy (UK GPhC-registered), after online consultation
MOJO WISDOM
Take control of your health by understanding your condition and what this medication is doing for you.
READ:
More information about this treatment.
UK-based doctors and pharmacists
Discreet and Confidential
UK-based doctors and pharmacists
Free, Expert Advice
No video link provided.
No video link provided.
UK-based doctors and pharmacists
Free, expert advice
Discrete and confidential
Fast delivery
Giving you trusted clinical advice for over 40 conditions
A UK regulated pharmacy providing safe, effective treatments online since 2014
When acid reflux, heartburn, or GORD is taking over your meals and your evenings, pantoprazole is one of the most well-tolerated proton pump inhibitors available, with a particularly clean drug interaction profile that makes it the PPI of choice for patients on clopidogrel, methotrexate, or multiple medicines where interactions matter.
At Courier Pharmacy, we believe acid-related care should suit the person, not the marketing budget. Whether you’re managing recent-onset reflux, a flare of GORD, an active stomach ulcer, NSAID-related gastric protection, or you’ve moved to pantoprazole specifically because of its lower interaction risk with other medicines you take, this page is here to help you decide whether Pantoprazole 20mg tablets fit your situation, and how to use them well.
Five key takeaways
Pantoprazole 20mg tablets is a UK Prescription Only Medicine (POM) for the treatment and maintenance of mild to moderate reflux disease (GORD), mild reflux oesophagitis, and the long-term prevention of reflux recurrence.
Pantoprazole has a notably cleaner drug interaction profile than omeprazole and esomeprazole, which is why it is often the preferred PPI for patients on clopidogrel, methotrexate, or with complex polypharmacy.
The 20mg dose is the standard adult treatment strength for mild to moderate disease and long-term maintenance; the 40mg dose is used for moderate to severe oesophagitis and Helicobacter pylori eradication.
Standard adult dose: one 20mg tablet once daily, taken in the morning, swallowed whole with water, ideally an hour before food.
Long-term PPI use carries small but real class risks (low magnesium, low vitamin B12, slight increase in fracture and Clostridioides difficile infection risk), which is why prescriber review is built into our service.
Treatment dosage: Pantoprazole 20mg tablets
Always follow the dosing instructions from your prescriber. The information below is based on standard BNF and SmPC guidance for Pantoprazole 20mg tablets.
For mild to moderate GORD and reflux symptoms in adults: 20mg once daily for 4 weeks, extended to a further 4 weeks if symptoms have not fully resolved.
For mild reflux oesophagitis in adults: 20mg once daily for 4 to 8 weeks.
For long-term maintenance of GORD (after initial healing): 20mg once daily, with regular review to determine whether ongoing treatment is needed.
For prevention of NSAID-associated ulcers in patients with risk factors who need to continue an NSAID: 20mg once daily for the duration of NSAID treatment.
For moderate to severe reflux oesophagitis, gastric and duodenal ulcers, and Helicobacter pylori eradication regimens, the 40mg dose is used, often twice daily for eradication. The 20mg tablet is not the appropriate strength for these indications and we would supply the 40mg tablet instead.
Swallow the tablet whole with a glass of water. The gastro-resistant coating around the tablet is essential, because pantoprazole is degraded by stomach acid; the coating protects the tablet until it reaches the small intestine where it can be absorbed. Do not crush, chew, or break the tablet, because this destroys the gastro-resistant coating and inactivates the pantoprazole.
Take pantoprazole in the morning, around an hour before breakfast. PPIs work best when the proton pumps are activated by an oncoming meal, which is why pre-meal dosing produces better acid suppression than dosing at any other time. Pantoprazole is licensed for once-daily morning dosing for most indications.
Do not stop pantoprazole abruptly after long-term use without prescriber advice. PPIs cause a rebound increase in acid secretion when stopped suddenly after months or years of use, which can produce a few weeks of worse-than-baseline symptoms. A gradual taper, sometimes with bridging H2 antagonist cover, is usually more comfortable.
Overview of Pantoprazole 20mg tablets
Pantoprazole is one of the original first-generation proton pump inhibitors, with three decades of clinical experience behind it.
The 20mg dose produces acid suppression that is clinically comparable to omeprazole 20mg, esomeprazole 20mg, or lansoprazole 15mg for mild to moderate disease.
Pantoprazole has the lowest CYP2C19 inhibition of all the licensed PPIs, which is why it is often preferred for patients on clopidogrel or other CYP2C19-sensitive medicines.
The 20mg dose is the standard maintenance and mild-to-moderate treatment strength; the 40mg dose is used for more severe disease and for H. pylori eradication.
Long-term PPI use carries small but real class risks (low magnesium, low vitamin B12, fracture, C. difficile) that warrant regular prescriber review, regardless of which PPI is used.
GORD and acid-related conditions are remarkably common. NICE estimates that around 1 in 4 UK adults experience reflux symptoms at least monthly, and a meaningful proportion of those will benefit from PPI treatment at some point. The standard approach is to use a 4 to 8 week course of a PPI, then review whether the symptoms have resolved, whether maintenance treatment is needed, or whether a different diagnosis should be considered.
Pantoprazole sits in a specific position in the gastric care toolkit. NICE guidance recommends omeprazole or lansoprazole as the first-line PPI in most cases on cost-effectiveness grounds, with pantoprazole, esomeprazole, or rabeprazole as alternatives where there is a clinical reason to switch. The most common reason to choose pantoprazole specifically is a drug interaction concern: a patient on clopidogrel after a heart attack or stent, a patient on methotrexate for rheumatological or skin disease, a patient on multiple CYP2C19-sensitive medicines, or a patient who has not tolerated another PPI well. For these patients, pantoprazole is often the safest and most pragmatic choice.
The decision between PPIs in patients without specific interaction concerns is less critical clinically. Omeprazole, lansoprazole, pantoprazole, esomeprazole, and rabeprazole all produce broadly similar acid suppression at standard doses, and the clinical evidence shows broadly similar healing rates for mild to moderate GORD and oesophagitis. The differences become more meaningful at the higher doses needed for severe disease and for patients with specific tolerability or interaction issues.
The decision to start pantoprazole isn’t just about prescribing a tablet. It’s about thinking through whether reflux symptoms are typical and self-limiting, whether they’re severe enough to warrant PPI treatment, whether they could be something else (cardiac chest pain, gastric cancer in older patients with red-flag symptoms, eosinophilic oesophagitis, achalasia), and whether lifestyle modifications could play a role alongside the medicine. Our prescriber will work through these questions during your consultation.
A note on long-term use. PPIs were originally developed for short-term ulcer healing, but many patients end up on them for years, sometimes appropriately and sometimes not. The benefit/risk balance shifts a little with duration: short courses are very safe, while long-term use carries small but real risks that warrant active management rather than passive continuation. Our prescriber-led approach builds review into the supply pattern, so you’re not simply on pantoprazole forever by default. Healthcare that fits the person, not the other way round.
Why choose Courier Pharmacy for Pantoprazole 20mg tablets
At Courier Pharmacy, our whole approach is built around the idea that healthcare should fit the person. For pantoprazole, that often means careful attention to drug interactions and complex medicine lists.
Many patients on pantoprazole have been specifically switched to it from another PPI because of clopidogrel, methotrexate, or a more complex polypharmacy picture, and our prescriber will check whether that choice still fits your current medicines and your current clinical situation.
Our service is shaped by the philosophy of Dr Ada Jex-Cori, our brand pharmacist, who has built her practice around accessible, honest, personalised care. Her view is straightforward: you are not broken. The system is the problem. We are here to change that.
We know that many patients have been on PPIs for years without much attention to whether they’re still needed at the same dose. Our prescriber-led model is designed to catch that, with a structured review at the supply point rather than a passive repeat.
For patients who started pantoprazole because of an interaction concern that has since resolved (clopidogrel course completed, methotrexate stopped), our prescriber can talk through whether you can safely move to a more cost-effective PPI option such as omeprazole. For patients with complex acid-related histories, including those with overlapping MCAS, fibromyalgia, or chronic fatigue picture (where PPI use is often part of a wider medicines list), we can think about excipient sensitivities and consider whether a different formulation or even a compounded option might suit better. MCAS care that takes you seriously means looking at the whole picture, not just signing off the next 28 tablets.
Trust is the part that has to be earned, not claimed. We’re GPhC-regulated, we ground our content in NHS, NICE, BNF, and peer-reviewed sources, and we will tell you honestly if pantoprazole isn’t the right answer for your situation, including referring you for endoscopy or specialist review where red-flag symptoms warrant it. We’d rather give you the right answer than a quick sale.
Buy Pantoprazole 20mg tablets (Prescription Only) from Courier Pharmacy
Pantoprazole 20mg tablets is a Prescription Only Medicine (POM) in the UK. It can only be supplied after a UK-qualified prescriber has reviewed your online consultation. The consultation takes a few minutes and covers your symptoms, medical history, current medicines, and treatment goals.
Here is how our service works:
Complete a quick online consultation answering questions about your symptoms, medical history, and current medications.
A UK-qualified prescriber reviews your answers to confirm pantoprazole is suitable for you.
If approved, a prescription is issued and your order is prepared for dispatch.
We dispense and deliver discreetly to your door.
If Pantoprazole 20mg tablets isn’t suitable for you, we will explain why and suggest the next best option. That might be a different dose (40mg for moderate to severe oesophagitis or H. pylori eradication), a different PPI (such as omeprazole or lansoprazole as a more cost-effective first-line option in patients without interaction concerns), an H2 antagonist (such as famotidine) for milder symptoms or short-term use, or a referral to your GP or for endoscopy if your symptoms suggest something that needs a clinical look.
Our free fortnightly drop-in clinics at Insomnia, Derby run every other week from 10 am to 12 pm. Reflux, dyspepsia, PPI long-term use, switching between PPIs, and “should I still be on this?” are all conversations we have regularly at these sessions. No appointment needed, no charge, no pressure.
Active ingredient in Pantoprazole 20mg tablets
The active ingredient is pantoprazole, typically formulated as pantoprazole sodium sesquihydrate in licensed UK products (with each tablet delivering 20mg of pantoprazole base). Pantoprazole is a substituted benzimidazole that selectively inhibits the H+/K+ ATPase enzyme (the "proton pump") in gastric parietal cells. Like the other PPIs, it is a prodrug that is activated only in the acidic environment of the parietal cell's secretory canaliculus, which is why the active drug accumulates specifically where it needs to act and produces minimal effects elsewhere.
Each tablet is gastro-resistant (enteric-coated), which is essential because pantoprazole is acid-labile and would be destroyed by stomach acid before absorption if it weren't protected. The coating dissolves only in the slightly alkaline environment of the small intestine, where pantoprazole is absorbed into the bloodstream and then concentrated in the gastric parietal cells via the bloodstream supply to the stomach wall. The result is a medicine that is protected on its way down, absorbed efficiently, and then targeted back to the exact tissue it needs to act on.
The pharmacological distinctiveness of pantoprazole among PPIs lies in two areas. First, pantoprazole is more chemically stable in mildly acidic conditions than omeprazole or lansoprazole, which means it is less prone to non-specific activation outside the parietal cell. Second, pantoprazole is metabolised primarily by CYP2C19 in the liver but is itself a much weaker inhibitor of CYP2C19 than omeprazole, esomeprazole, or lansoprazole. The clinical consequence is a cleaner drug interaction profile, particularly with medicines like clopidogrel, methotrexate, citalopram, phenytoin, and diazepam that depend on CYP2C19 metabolism.
What are Pantoprazole 20mg tablets used for?
Pantoprazole 20mg tablets is licensed in the UK for the following indications.
For mild to moderate gastro-oesophageal reflux disease (GORD) in adults, pantoprazole 20mg is the standard treatment dose, typically given for 4 weeks and extended to 8 weeks if needed.
For mild reflux oesophagitis in adults, pantoprazole 20mg is appropriate for 4 to 8 weeks of treatment, followed by review.
For long-term maintenance of GORD after initial healing, pantoprazole 20mg once daily is the typical maintenance dose, with regular prescriber review to determine whether ongoing treatment remains necessary.
For prevention of NSAID-associated ulcers in patients with risk factors (age over 65, previous ulcer history, concurrent steroid or anticoagulant use) who need to continue long-term NSAID treatment, pantoprazole 20mg once daily is appropriate for the duration of NSAID treatment.
For more severe acid-related conditions (severe reflux oesophagitis, gastric and duodenal ulcers, H. pylori eradication regimens, Zollinger-Ellison syndrome), the higher-strength pantoprazole 40mg tablet is the appropriate choice. We can supply 40mg as a separate product after consultation.
For non-licensed but commonly accepted off-label uses, prescribers may use pantoprazole 20mg for mild dyspepsia not responding to lifestyle changes and OTC treatment, and for gastric protection alongside other medicines in lower-risk patients.
It is not appropriate for self-treatment of red-flag symptoms. Persistent vomiting, vomiting blood, dark or tarry stools, unexplained weight loss, difficulty swallowing, or new onset of symptoms in patients over 55 require GP assessment to rule out gastric cancer and other serious causes before assuming reflux is the diagnosis.
How does Pantoprazole work?
Pantoprazole works by directly inhibiting the H+/K+ ATPase enzyme (the proton pump) in gastric parietal cells. The proton pump is the final common step in gastric acid secretion, the point where the parietal cell actively transports hydrogen ions (the acid component) from inside the cell into the gastric lumen in exchange for potassium ions. By blocking this pump, pantoprazole reduces gastric acid secretion regardless of what's stimulating it (histamine, acetylcholine, gastrin, or food itself).
This is what distinguishes PPIs from older H2-receptor antagonists like famotidine. H2 antagonists block one of the stimulating signals to the parietal cell (histamine binding to H2 receptors), but the parietal cell still responds to other signals. PPIs block the final pump itself, which produces more complete and more sustained acid suppression. After repeat dosing at steady state, pantoprazole 20mg typically holds intragastric pH above 4 for around 11 to 13 hours per 24 hours, comparable to omeprazole 20mg, esomeprazole 20mg, or lansoprazole 15mg.
After you swallow a pantoprazole tablet, the gastro-resistant coating protects the medicine from stomach acid as the tablet passes through the stomach. The tablet reaches the small intestine, the coating dissolves, and pantoprazole is rapidly absorbed. Absorbed pantoprazole travels via the bloodstream to the gastric parietal cells, where it accumulates in the acidic secretory canaliculus. There, the acidic environment activates the prodrug into its active form, which then irreversibly binds to the H+/K+ ATPase pump.
The irreversible binding has interesting clinical consequences. Once a pump is inhibited, it stays inhibited until the parietal cell synthesises a new one, which takes around 24 to 36 hours. This means the duration of acid suppression from pantoprazole is much longer than the duration of pantoprazole itself in the bloodstream (the plasma half-life is around 1 hour). It also means that the effect of pantoprazole builds over the first few days of treatment as more and more pumps are inhibited, reaching steady state at around day 5 to 7. Patients should be told to expect gradually improving symptoms over the first week rather than instant relief.
The pharmacokinetic distinctiveness of pantoprazole compared with other PPIs is in its drug interaction profile rather than its acid suppression depth. Pantoprazole's chemical structure means it inhibits CYP2C19 much less than omeprazole, esomeprazole, or lansoprazole. The clinical consequence is that patients on pantoprazole experience fewer significant interactions with clopidogrel, methotrexate, citalopram, phenytoin, diazepam, warfarin, and other CYP2C19-dependent medicines. For most patients without these interactions to worry about, the practical clinical difference between pantoprazole and the other PPIs is small, but for patients on those medicines, the difference can be meaningful.
How to use Pantoprazole 20mg tablets
Take one 20mg tablet once daily, in the morning, around an hour before breakfast. The pre-meal timing matters because the proton pumps are activated by the prospect of food, and pantoprazole works best when it's in the bloodstream and ready to bind to activated pumps as they appear.
Swallow the tablet whole with a glass of water. Do not crush, chew, or break the tablet, because this destroys the gastro-resistant coating and inactivates the pantoprazole. Pantoprazole tablets are not designed to be dispersed in water or opened, unlike some other PPI capsule formats; if you have significant swallowing difficulties, discuss alternative formulations with our prescriber during the consultation.
Take pantoprazole consistently at the same time each day. Skipping doses produces incomplete acid suppression, which can prolong healing of mild oesophagitis. If you miss a dose, take it as soon as you remember unless it's nearly time for the next dose; don't double-dose to catch up.
Most acid-related conditions respond within 4 to 8 weeks. If your symptoms haven't improved by the end of the prescribed course, contact your prescriber for a review rather than continuing indefinitely. Persistent symptoms despite a full course of pantoprazole may suggest a different diagnosis, the need for a different dose or PPI, or that endoscopy is warranted.
Don't stop pantoprazole abruptly after long-term use. PPIs cause rebound acid hypersecretion when stopped suddenly after several months of use, which can produce a few weeks of unpleasant symptoms even in patients who no longer need treatment. A gradual taper (for example, reducing to once-every-other-day for two weeks before stopping, sometimes with H2 antagonist cover) is usually more comfortable.
Warnings and precautions for Pantoprazole 20mg tablets
Pantoprazole is well-tolerated by most patients, but a few cautions apply.
Do not use pantoprazole if you have a known hypersensitivity to pantoprazole, to other substituted benzimidazoles (omeprazole, esomeprazole, lansoprazole, rabeprazole), or to any of the tablet excipients.
Use with caution in significant liver impairment, as pantoprazole is metabolised in the liver and dose reduction may be needed (the SmPC suggests maximum 20mg daily in severe liver impairment, with monitoring of liver enzymes if treatment continues). Renal impairment generally does not require dose adjustment.
In older patients, particularly those with multiple medical conditions and multiple medicines, the long-term risks of PPI use deserve more careful weighing against the benefits. The main long-term concerns are reduced magnesium absorption (which can cause symptomatic hypomagnesaemia, particularly after a year or more of use), reduced vitamin B12 absorption (more relevant after several years of use), a small increase in the risk of Clostridioides difficile infection (particularly in hospital settings), and a small increase in the risk of hip and vertebral fracture (more relevant in older patients with other fracture risk factors). These risks are small and should not stop appropriate PPI use; they are reasons for ongoing review rather than reasons for avoidance.
Pre-existing red-flag symptoms (vomiting blood, dark stools, unexplained weight loss, persistent vomiting, difficulty swallowing, new onset of dyspepsia after age 55) need a proper assessment before starting pantoprazole, because the medicine can mask symptoms of more serious underlying disease, including gastric cancer.
In pregnancy and breastfeeding, pantoprazole is generally considered low-risk based on observational data, although the safety database is smaller than for omeprazole. Omeprazole has the largest pregnancy safety dataset of any PPI and is often preferred where a PPI is needed in pregnancy. If you become pregnant while taking pantoprazole, discuss with your prescriber whether switching to omeprazole would be sensible. Use the lowest effective dose for the shortest necessary duration during pregnancy.
In children, pantoprazole is licensed for use in some paediatric age groups but supply through this online consultation route is restricted to adults. Children's care should go through a paediatric route.
A specific warning relates to severe cutaneous adverse reactions. Subacute cutaneous lupus erythematosus has been reported with PPI use, including pantoprazole. If a new rash develops, particularly on sun-exposed skin, stop the medicine and seek medical advice.
Side effects of Pantoprazole 20mg tablets
Like all medicines, pantoprazole can cause side effects, though most patients tolerate it well. The side effect profile is broadly similar across all the PPIs as a class, with no major differences between pantoprazole and the others.
Common side effects (affecting up to 1 in 10 patients) include headache, abdominal pain, nausea, diarrhoea, constipation, flatulence, and benign fundic gland polyps (small, harmless polyps that can develop in the stomach with long-term use and don't require treatment).
Less common side effects include skin rash, dizziness, drowsiness, insomnia, sleep disturbance, transient elevation of liver enzymes, peripheral oedema, dry mouth, paraesthesia, and taste disturbance.
Rare side effects include more significant skin reactions (urticaria, photosensitivity), arthralgia, myalgia, blood dyscrasias including thrombocytopenia, and reversible mental confusion (mainly in elderly patients).
Very rare but serious side effects include severe skin reactions (Stevens-Johnson syndrome, toxic epidermal necrolysis), severe liver injury, severe blood disorders, interstitial nephritis, and subacute cutaneous lupus erythematosus. If you notice any severe rash, blistering, jaundice, dark urine, fever with rash, or sudden swelling, stop the medicine and seek urgent medical attention.
Long-term use side effects deserve specific mention because they are managed by review rather than by avoidance.
Low magnesium can develop after 3 months or more of PPI use and is more likely after a year or more. Symptoms include fatigue, muscle cramps, tremor, weakness, and occasionally seizures or cardiac arrhythmias. A magnesium blood test is sensible for any patient who has been on a PPI for more than a year and develops unexplained symptoms.
Low vitamin B12 can develop after several years of PPI use, particularly in older patients with limited B12 intake. Symptoms include fatigue, mood changes, neurological symptoms (numbness, tingling), and anaemia. A B12 level is reasonable to check after several years of continuous use.
Increased C. difficile infection risk is mainly a concern in hospital settings, where PPI use combined with broad-spectrum antibiotics can predispose to C. difficile colitis. The community risk is much smaller but not zero; new-onset diarrhoea in a patient on pantoprazole should not automatically be assumed to be drug-related, and prompt review is appropriate.
Increased fracture risk (hip, wrist, spine) is small but real with long-term high-dose PPI use, particularly in older patients with other osteoporosis risk factors. It's a reason to ensure that long-term PPI use is at the lowest effective dose, alongside attention to calcium, vitamin D, weight-bearing exercise, and other bone health measures.
Yellow Card reporting: report suspected adverse drug reactions to the MHRA via the Yellow Card scheme at yellowcard.mhra.gov.uk. Reporting helps build the safety picture for everyone.
Drug interactions with Pantoprazole 20mg tablets
Pantoprazole has a notably cleaner drug interaction profile than other PPIs, which is one of the main reasons prescribers choose it for patients on multiple medicines. The interactions listed below are real but are generally less clinically significant than the equivalent interactions with omeprazole, esomeprazole, or lansoprazole.
Clopidogrel is a key example. Clopidogrel is a prodrug that needs CYP2C19 to be activated to its antiplatelet form. PPIs that strongly inhibit CYP2C19 (omeprazole and esomeprazole in particular) can reduce the antiplatelet effect of clopidogrel and theoretically increase cardiovascular risk in patients taking clopidogrel after a stent or after a heart attack. Pantoprazole inhibits CYP2C19 much less than omeprazole or esomeprazole, and is consequently recommended by the MHRA and most cardiology guidelines as the preferred PPI for patients on clopidogrel where gastric protection is needed. This is the single most common reason patients are switched specifically to pantoprazole.
Methotrexate can have its excretion reduced by PPIs at high oncology doses, leading to potentially toxic methotrexate levels. The interaction is small with pantoprazole and is generally not clinically significant at the low weekly doses used for rheumatological conditions. Patients on high-dose methotrexate should still discuss PPI use with their oncology or rheumatology team.
HIV medicines. The acid-dependent absorption of atazanavir and rilpivirine is reduced by PPIs, including pantoprazole. Combining is generally not recommended; specialist HIV advice is needed where co-administration is unavoidable. The pantoprazole interaction with nelfinavir is smaller than that of omeprazole but still warrants caution.
Azole antifungals. Ketoconazole, itraconazole, and posaconazole need an acidic stomach for proper absorption, and PPIs (including pantoprazole) reduce their absorption. Where systemic antifungal treatment is needed alongside PPI therapy, fluconazole (which does not require gastric acid for absorption) is often preferred, or a different acid-suppression strategy.
Warfarin can have its effect altered by pantoprazole through small effects on CYP2C19 and CYP2C9. The interaction is less significant than with omeprazole, but INR monitoring is sensible when starting or stopping pantoprazole in patients on warfarin.
Other CYP2C19 substrates (citalopram, escitalopram, diazepam, phenytoin) are affected much less by pantoprazole than by omeprazole or esomeprazole. For patients on these medicines, pantoprazole is generally the safer PPI choice, particularly in older patients or where the dose of the other medicine is already optimised.
Iron supplements and some iron salts have reduced absorption when PPIs are used, because dietary iron requires gastric acid for optimal absorption. For patients who need iron supplementation alongside long-term PPI therapy, taking iron with vitamin C or considering an alternative iron form may help.
Tacrolimus and other immunosuppressants can have their levels affected by pantoprazole, although the interaction is smaller than with omeprazole. Patients on tacrolimus should have levels monitored when starting or stopping a PPI.
For patients on any of the medicines above, our prescriber will check the interaction profile during your consultation. If you have specifically been moved onto pantoprazole because of a drug interaction concern with another PPI, our prescriber will confirm this is still the right choice for your current medicine list.
Frequently asked questions about Pantoprazole 20mg tablets
What is Pantoprazole 20mg used for?
Pantoprazole 20mg tablets is used for the treatment and maintenance of mild to moderate acid-related conditions, including gastro-oesophageal reflux disease (GORD), mild reflux oesophagitis, long-term maintenance of reflux disease after initial healing, and the prevention of NSAID-associated ulcers. The standard adult dose is one tablet once daily.
Why has my GP put me on pantoprazole rather than omeprazole?
The most common reason is a drug interaction concern. Pantoprazole has the cleanest drug interaction profile of any PPI, which makes it the preferred choice for patients on clopidogrel (after a stent or heart attack), methotrexate, citalopram, phenytoin, diazepam, or warfarin. It is also often chosen for patients on multiple medicines where interaction risk is harder to manage with omeprazole or esomeprazole. NICE and the BNF specifically recommend pantoprazole as the preferred PPI for patients on clopidogrel.
What's the difference between pantoprazole and other PPIs?
Pantoprazole, omeprazole, lansoprazole, esomeprazole, and rabeprazole all work through the same mechanism (proton pump inhibition) and produce broadly similar acid suppression at standard doses. The differences are in drug interaction profile (pantoprazole has the cleanest), cost (omeprazole and lansoprazole are generally cheapest), and dose-equivalence (pantoprazole 20mg is roughly equivalent to omeprazole 20mg, lansoprazole 15mg, esomeprazole 20mg). Pantoprazole is generally chosen where interaction risk matters; omeprazole or lansoprazole are usually first-line otherwise.
How quickly does pantoprazole start working?
Some symptom relief can be felt within the first few days, but the full effect builds over the first week as more proton pumps are inhibited. Most patients see a clear improvement by day 5 to 7. For mild oesophagitis healing, the medicine continues to work over the full 4 to 8 week course, even if symptoms resolve sooner.
When should I take my pantoprazole?
In the morning, around an hour before breakfast. PPIs work best when the proton pumps are activated by oncoming food, which is why pre-meal dosing produces better acid suppression than post-meal or random timing. Be consistent with the timing each day.
Can I crush or chew pantoprazole tablets?
No. Pantoprazole tablets are gastro-resistant (enteric-coated), and crushing or chewing destroys the coating and inactivates the medicine. The tablet must be swallowed whole. Unlike some PPI capsule formats, pantoprazole tablets are not licensed for dispersion in water or opening. If you have significant swallowing difficulties, discuss alternative formulations with our prescriber.
How long can I take pantoprazole for?
The licensed treatment courses are 4 to 8 weeks for most acid-related conditions, with maintenance treatment where appropriate. Long-term use is common and often necessary, but should be reviewed regularly to ensure it's still needed and to use the lowest effective dose. Our prescriber will build this into your supply pattern.
Is long-term pantoprazole safe?
Long-term PPI use is generally safe but carries small risks that warrant active monitoring: low magnesium (after a year or more), low vitamin B12 (after several years), small increase in C. difficile risk, and small increase in fracture risk. These are reasons for regular review rather than reasons to avoid appropriate use. The class risks apply equally to pantoprazole and the other PPIs.
Can I stop pantoprazole suddenly?
If you've been on pantoprazole for less than a few weeks, you can usually stop without significant rebound. For long-term users (months or years), stopping abruptly often causes rebound acid hypersecretion and unpleasant symptoms for a few weeks. A gradual taper, sometimes with H2 antagonist cover, is more comfortable.
Can I take pantoprazole with antacids like Gaviscon?
Yes. Antacids and PPIs work through different mechanisms and can be taken together. Antacids neutralise existing acid for quick symptom relief; PPIs reduce acid production for sustained effect. Many patients use Gaviscon or another antacid for breakthrough symptoms during the first few days of starting pantoprazole, before the PPI effect has fully built up.
Can I take pantoprazole with clopidogrel?
Yes, and this is one of the main reasons pantoprazole is prescribed. Pantoprazole has much less effect on the CYP2C19 enzyme that activates clopidogrel than omeprazole or esomeprazole, which is why it is recommended as the preferred PPI for patients on clopidogrel who need gastric protection.
Is pantoprazole safe in pregnancy?
Pantoprazole is considered low-risk in pregnancy based on observational data, but the safety database is smaller than for omeprazole. Omeprazole has the largest pregnancy safety dataset of any PPI and is often preferred when a PPI is needed in pregnancy. Discuss with your prescriber if you are or might become pregnant.
Can pantoprazole cause weight gain?
There's no strong evidence that pantoprazole directly causes weight gain. Some patients report changes in appetite or eating patterns once reflux is controlled (because they're no longer avoiding foods that triggered symptoms), which can secondarily affect weight.
What if my symptoms come back after I stop pantoprazole?
Two possibilities. First, rebound acid hypersecretion is common in the first 2 to 4 weeks after stopping long-term PPI use, and usually settles. Second, your original condition may genuinely need ongoing treatment. If symptoms return persistently after a proper taper-off period, contact your prescriber for a review and possibly a return to PPI treatment or a different long-term plan.
Can pantoprazole interact with other medicines?
Yes, but generally less than other PPIs. The cleanest interaction profile is one of the main reasons pantoprazole is chosen. Notable interactions include atazanavir, rilpivirine, ketoconazole, itraconazole, posaconazole (reduced absorption), high-dose methotrexate (small effect), and iron salts. Warfarin, citalopram, diazepam, phenytoin, and tacrolimus are affected much less than with omeprazole. List all your medicines during the consultation.
Do I need a blood test before or during pantoprazole treatment?
Not routinely for short courses. For long-term use (more than a year), a magnesium level is sensible, and a B12 level becomes reasonable after several years. Patients on diuretics or other medicines that can lower magnesium may need earlier monitoring.
Should I see a doctor about my reflux symptoms?
See your GP if you have any red-flag symptoms (vomiting blood, dark stools, unexplained weight loss, persistent vomiting, difficulty swallowing, new symptoms over age 55), if symptoms persist despite a full course of PPI, or if you've been on a PPI for years without a clear review. Endoscopy is sometimes warranted.
How should I store pantoprazole?
Store at room temperature, below 25°C (some brands specify below 30°C), in the original packaging to protect from moisture. Keep out of sight and reach of children. Do not use after the expiry date printed on the pack.
Can people with MCAS take pantoprazole?
Yes, in most cases. Some MCAS patients are sensitive to PPI excipients, in which case switching to a different brand or considering a compounded formulation can help. PPIs can also be a useful part of MCAS management itself because of their adjunctive effects on gastric mast cell-related symptoms, although this is off-label. Pantoprazole's particularly clean interaction profile can be a real advantage in MCAS patients who are often on multiple medicines. Discuss your full medical picture during the consultation.
How do I order Pantoprazole 20mg tablets from Courier Pharmacy?
Complete the online consultation at courierstaging.mystagingwebsite.com. A UK-qualified prescriber will review your answers, issue a prescription if appropriate, and our pharmacy team will dispense and deliver discreetly. Free pharmacist support is available before and after you order.
Disclaimer: This article is for general information only and isn’t a substitute for personal medical advice, diagnosis, or treatment. Always check with a GP, pharmacist, or specialist before starting a new supplement if you have a medical condition or take regular medicines.
More than a prescription: our community
Healthcare shouldn't only happen when you're paying for it. Every fortnight we run free drop-in talks and clinics at Insomnia, Derby, from 10 am to 12 pm. Bring a question, bring a friend, bring a stack of bewildering letters from another clinic; we'll sit with you. We cover acid reflux, GORD, PPI long-term use, hair loss, men's health, MCAS, fibromyalgia, low-dose naltrexone, and whatever else people bring through the door. No appointment. No cost. No pressure. Learn more about our community talks.
How this content was created
Written by the Courier Pharmacy editorial team and reviewed by a GPhC-registered pharmacist. Grounded in the latest NHS, NICE, BNF and EMC guidance, peer-reviewed studies, and the real questions patients bring to our drop-in clinics in Derby.
References
[1] Electronic Medicines Compendium (emc) (n.d.) [Product name not specified] – Summary of Product Characteristics (SmPC). Available at: https://www.medicines.org.uk/emc/product/7089/smpc (Accessed: 14 May 2026).
